JAGGAER, Science Exchange, and other Industry Leaders Address Top Digital Transformation Challenges for Research-Intensive Companies 2019

RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Elizabeth Iorns, Ph.D., CEO of Science Exchange, Inc., James Lillie, Ph.D., Chief Scientific Officer at OvaScience, Inc., and Tom Russell, VP of Enterprise Solutions at JAGGAER, will discuss the top issues driving biopharma digital transformation in 2019, on the December 6, 2018 edition of JAGGAER’s InsideSpend webinar and podcast series. JAGGAER is the world’s largest independent spend management company, Science Exchange is the world’s leading marketplace for outsourced research services, and OvaScience is a publicly traded biotechnology company, focused on female infertility. This webinar is designed to provide actionable intelligence and insights for Chief Procurement Officers, VPs, and Directors and Managers of procurement locally and globally. 

Register here for the 11:00 AM EST live webinar.

The need for digital transformation moves to the forefront in 2019 as research-intensive companies continue to face increased supply chain risk, pricing pressures, high cost of M&A, more competition, and the drive toward specialized technologies. The end result is a stakeholder mandate to create more efficiencies internally. Digitizing processes can enable these companies to more effectively engage suppliers, save costs, increase productivity, and decrease time-to-market for R&D initiatives. JAGGAER has been servicing this industry for over twenty years with a unique inventory product, Enterprise Reagent Manager, and has added novel supplier networks to the mix to meet increased demands for specialization.

According to a recent Deloitte survey, only 20% of biopharma companies, a key research-intensive sector, are maturing digitally, with initiatives that embrace everything from manufacturing and supply chain to highly skilled and niche scientific specific supplier networks.

“Today’s biopharma companies often lag in terms of digital capabilities, but we’re seeing many organizations starting to transform how they procure scientific services and conduct R&D, to drive efficiencies across their business,” observes Dr. Iorns of Science Exchange.

“At a large biopharma, Science Exchange turns a 6-month process [of contracting with a provider] into immediate access through a digital channel. At a smaller company, you don’t always have access to expertise within your budget,” says Dr. James Lillie, who has leading R&D at OvaScience after years of leading R&D at pharma multinational Sanofi.

Collectively, Iorns, Lillie and Russell will explore the digital transformation challenges facing biopharma companies, the availability of new supplier networks, strategies for mitigating and circumventing risk, time and project assessments of digital transformation projects, and expected outcomes. They will discuss the concepts of building digital twins, virtual drug development, and conduct a run-down of 2018 industry news that will impact 2019.  This promises to be a must-see webinar for any company seeking to tackle the uncertainty of the next 12 months.

About JAGGAER: Global Source to Pay Spend Management Solutions   JAGGAER is the world’s largest independent spend management company, with nearly 2000 customers connected to a network of 3.7 million suppliers in 70 countries, served by offices located in North America, Latin America, throughout Europe, the United Kingdom, Australia, Asia, and the Middle East. JAGGAER offers complete SaaS-based Source to Pay eProcurement solutions with advanced Spend Analytics, Sourcing, Supplier Management, Contract Lifecycle Management, Savings Tracking, and intelligent workflow capabilities. JAGGAER has pioneered spend solutions for over two decades and continues to lead the innovation curve by listening to customers and analyzing the market. Our solution suites are trusted by the world’s largest manufacturing, education, health care, retail, consumer package goods, logistics, construction, utilities companies and public service organizations. Additionally, JAGGAER holds 38 patents–more than any other spend management company. www.JAGGAER.com

About Science Exchange  Science Exchange is the world's leading marketplace for outsourced R&D, providing large R&D organizations with the fastest path from discovery through development and commercialization. Science Exchange provides an efficient source-to-pay platform for ordering 6,000+ services from a network of more than 2,500 qualified research providers, all with pre-established contracts in place that protect client intellectual property and confidentiality. The platform increases access to innovation and improves productivity, freeing scientists from administrative tasks and delays associated with sourcing and managing service provider contracts. Additionally, the Science Exchange enterprise offering enables large R&D organizations to consolidate research outsourcing spend into a single strategic relationship, driving further efficiency, transparency, and cost savings. Since being founded in 2011, Science Exchange has raised more than $58 million from Norwest Venture Partners, Maverick Capital Ventures, Union Square Ventures, Collaborative Fund, Index Ventures, OATV, the YC Continuity Fund, and others. For more information, visit www.ScienceExchange.com. Follow the company on Twitter @ScienceExchange, Facebook, and LinkedIn.

To join the conversation, please visit our blog at https://JAGGAER.com/blog/ or follow us on Twitter @JaggaerProMEDIA CONTACT: JAGGEAR: [email protected] 919-659-2601

You May Also Be Interested In

• Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
• RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
• Medigene AG reports Financial Results and Business Update for Q1 2024